Effect of glycemic control using glucose-insulin infusion on postoperative inflammatory responses, renal function, complications, and outcomes in major oral and maxiilfacial surgery
Not Applicable
Recruiting
- Conditions
- Patients who are schduled for radical operation of oral malignant tumors along with tissue reconstruction
- Registration Number
- JPRN-UMIN000015522
- Lead Sponsor
- Kagoshima University Medical and Dental Hospintal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Patients whose operation time is less than 8H or those who were not able to continue insulin infusion due to hypoglycemia.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method It is supposed that postoperative inflammatory responses, postoperative complications, and days required until discharge may be reduced by intraoperative glucose-insulin infusion.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways link glucose-insulin infusion to reduced postoperative inflammation in oral cancer surgery?
How does glucose-insulin infusion compare to standard glycemic control in preventing postoperative complications for oral tumor patients?
Which biomarkers predict improved renal function outcomes with intraoperative glycemic control in maxillofacial surgery?
What are the adverse event profiles of glucose-insulin infusion protocols in radical oral cancer operations?
Are there combination therapies enhancing glycemic control benefits during tissue reconstruction in head and neck malignancies?